Unlocking Obesity with Precision Medicine Powered by Genomics & Real-World Data
Time: 10:40 am
day: Day One
Details:
- Establishment of a First-in-Class Genomic–RWD Dataset: Developing a comprehensive, longitudinal clinical dataset of patients treated with GLP-1R agonists, integrating multi-omics with real-world data to enable deep cardiometabolic characterization
- Differentiating Data Utility: Clarifying the distinct yet complementary roles of genomic data and real-world evidence in supporting research and development
- Translational Insights Generation: Identifying the types of insights that can be unlocked by integrating clinical and genomic data from patients receiving GLP-1R agonist therapy
